tiprankstipranks
Silexion Therapeutics (SLXN)
NASDAQ:SLXN
US Market
SLXN
Silexion Therapeutics
RESEARCH TOOLSreports

Silexion Therapeutics (SLXN) Cash flow

214 Followers

Silexion Therapeutics Cash Flow

SLXN's free cash flow for Q4 2025 was $-3.02M. For the 2025 fiscal year, SLXN's free cash flow was decreased by $-2.41M and operating cash flow was $-3.02M. See a summary of the company’s cash flow.
Cash Flow
Dec 25Dec 24Dec 23Dec 22Dec 21
Operating Cash Flow
$ -10.82M$ -8.40M$ -4.53M$ -3.33M$ -1.41M
Investing Cash Flow
$ -14.00K$ -22.00K$ 573.00K$ -524.00K$ 0.00
Financing Cash Flow
$ 15.64M$ 5.10M$ 522.00K$ 2.75M$ 116.40M
End Cash Position
$ 6.08M$ 1.27M$ 4.64M$ 8.31M$ 38.94K
Free Cash Flow
$ -10.83M$ -8.42M$ -4.54M$ -3.38M$ -1.41M
Currency in USD

Silexion Therapeutics Cash Flow